396 related articles for article (PubMed ID: 34440154)
1. Vulvar Lichen Sclerosus from Pathophysiology to Therapeutic Approaches: Evidence and Prospects.
Corazza M; Schettini N; Zedde P; Borghi A
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440154
[TBL] [Abstract][Full Text] [Related]
2. Novel Therapeutic Approaches and Targets for Treatment of Vulvar Lichen Sclerosus.
Borghi A; Corazza M
Curr Pharm Biotechnol; 2021; 22(1):99-114. PubMed ID: 32416670
[TBL] [Abstract][Full Text] [Related]
3. The Potential Coexistence of Autoimmune Thyroid Diseases and Pediatric Vulvar
Dulska A; Bodziony J; Janik M; Drosdzol-Cop A
Children (Basel); 2024 Feb; 11(2):. PubMed ID: 38397367
[TBL] [Abstract][Full Text] [Related]
4. Treatment Options in Vulvar Lichen Sclerosus: A Scoping Review.
Singh N; Mishra N; Ghatage P
Cureus; 2021 Feb; 13(2):e13527. PubMed ID: 33786234
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic comparison between treatments for Vulvar Lichen Sclerosus: study protocol of a randomized prospective and controlled trial.
Belotto RA; Chavantes MC; Tardivo JP; Euzébio Dos Santos R; Fernandes RCM; Horliana ACRT; Pavani C; Teixeira da Silva DF
BMC Womens Health; 2017 Aug; 17(1):61. PubMed ID: 28793884
[TBL] [Abstract][Full Text] [Related]
6. Growing evidence for topical mometasone fuoroate in the treatment of Vulvar Lichen Sclerosus.
Virgili A; Corazza M; Minghetti S; Borghi A
Maturitas; 2015 Jan; 80(1):113-5. PubMed ID: 25449823
[TBL] [Abstract][Full Text] [Related]
7. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study.
Virgili A; Minghetti S; Borghi A; Corazza M
Br J Dermatol; 2013 Jun; 168(6):1316-24. PubMed ID: 23398459
[TBL] [Abstract][Full Text] [Related]
8. Vulvar lichen sclerosus in women of reproductive age.
Kolitz E; Gammon L; Mauskar M
Proc (Bayl Univ Med Cent); 2021 Feb; 34(3):349-351. PubMed ID: 33953458
[TBL] [Abstract][Full Text] [Related]
9. Expression of galectin-7 in vulvar lichen sclerosus and its effect on dermal fibroblasts.
Zhao Y; Zhao S; Li H; Qin X; Wu X
Oncol Lett; 2018 Aug; 16(2):2559-2564. PubMed ID: 30013650
[TBL] [Abstract][Full Text] [Related]
10. Outcome Measures in Adult Vulvar Lichen Sclerosus: A Systematic Review.
Morrel B; Ten Kate-Booij MJ; van Dijk C; Bramer WM; Burger CW; Pasmans SGMA; van der Avoort IAM
J Low Genit Tract Dis; 2024 May; ():. PubMed ID: 38709568
[TBL] [Abstract][Full Text] [Related]
11. Vulvar Lichen Sclerosus: Navigating Sex Hormone Dynamics and Pioneering Personalized Treatment Paradigm.
Popa A; Dumitrascu MC; Petca A; Petca RC; Sandru F
J Pers Med; 2024 Jan; 14(1):. PubMed ID: 38248777
[TBL] [Abstract][Full Text] [Related]
12. Proposition of a severity scale for lichen sclerosus: The "Clinical Lichen Sclerosus Score".
Erni B; Navarini AA; Huang D; Schoetzau A; Kind A; Mueller SM
Dermatol Ther; 2021 Mar; 34(2):e14773. PubMed ID: 33426761
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of 5-Aminolevulinic Acid (ALA)-Photodynamic Therapy (PDT) in Refractory Vulvar Lichen Sclerosus: Preliminary Results.
Zhang F; Li D; Shi L; Gu Y; Xu Y; Wu C
Med Sci Monit; 2021 Jan; 27():e927406. PubMed ID: 33411697
[TBL] [Abstract][Full Text] [Related]
14. Mometasone fuoroate 0.1% ointment in the treatment of vulvar lichen sclerosus: a study of efficacy and safety on a large cohort of patients.
Virgili A; Borghi A; Minghetti S; Corazza M
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):943-8. PubMed ID: 23879234
[TBL] [Abstract][Full Text] [Related]
15. The long-term clinical consequences of juvenile vulvar lichen sclerosus: A systematic review.
Morrel B; van Eersel R; Burger CW; Bramer WM; Ten Kate-Booij MJ; van der Avoort IAM; Pasmans SGMA
J Am Acad Dermatol; 2020 Feb; 82(2):469-477. PubMed ID: 31437545
[TBL] [Abstract][Full Text] [Related]
16. Treatment of vulvar lichen sclerosus with topical corticosteroids in children: a study of 72 children.
Casey GA; Cooper SM; Powell JJ
Clin Exp Dermatol; 2015 Apr; 40(3):289-92. PubMed ID: 25477189
[TBL] [Abstract][Full Text] [Related]
17. Measuring perceived benefit and disease-related burden in patients affected with vulvar lichen sclerosus after a standard topical corticosteroid treatment. Results from a cohort study using Pictorial Representation of Illness and Self-measure and Dermatology Life Quality Index.
Borghi A; Odorici G; Scuderi V; Valpiani G; Morotti C; Corazza M
Dermatol Ther; 2020 Nov; 33(6):e14334. PubMed ID: 32974986
[TBL] [Abstract][Full Text] [Related]
18. Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease.
Renaud-Vilmer C; Cavelier-Balloy B; Porcher R; Dubertret L
Arch Dermatol; 2004 Jun; 140(6):709-12. PubMed ID: 15210462
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of self-reported medical comorbidities in patients with vulvar lichen sclerosus: A single-center retrospective study.
Hu J; Hesson A; Haefner HK; Rominski S
Int J Gynaecol Obstet; 2021 May; 153(2):340-343. PubMed ID: 33184843
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.
Funaro D; Lovett A; Leroux N; Powell J
J Am Acad Dermatol; 2014 Jul; 71(1):84-91. PubMed ID: 24704090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
